Dendrite Announces Breakthrough Software and Support Product to Improve Pharmaceutical Sales Force Effectiveness.MORRISTOWN, N.J.--(BW HealthWire)--Sept. 25, 1997-- Force MultiplieRx Links Daily Prescription Data with ETMS ETMS Enhanced Traffic Management System ETMS Electronic Territory Management System ETMS Electronic Train Management System ETMS Education and Training Management System (USAF) ETMS Eidgenössische Trugwild Meldestelle Systems to Provide Fast Sales Response Capability Dendrite dendrite: see nervous system; synapse. International, Inc. (NASDAQ/NMS:DRTE DRTE Defence Research Telecommunications Establishment ), the leading supplier of customer management solutions for complex selling environments, today announced a breakthrough software and support product to help major pharmaceutical companies increase sales force effectiveness. Force MultiplieRx will enable U.S. pharmaceutical sales representatives pharmaceutical sales representative Detailer, Drug rep Drug industry A drug company employee who regularly visits physicians and office practices, providing information on the company's products–usually putting a negative 'spin' on competitors' products. See Detailing. to track physicians' daily prescribing trends and plan immediate sales promotion responses to prescribing changes. This will be particularly important to pharmaceutical sales representatives when marketing new products. Force MultiplieRx will be available in both an integrated form (with Dendrite's Series 6 products) and as a standalone product for sales representatives using other Sales Force Automation Automating the sales activities within an organization. A comprehensive SFA package provides such functions as contact management, note and information sharing, quick proposal and presentation generation, product configurators, calendars and to-do lists. systems. "This new product and service offering fits our strategy of going beyond sales force automation by improving the effectiveness of each sales person on every sales call," said John Bailye, President and Chief Executive Officer of Dendrite. "By partnering with pharmaceutical benefit management companies (PBMs), we can leverage each organization's unique strengths to provide more valuable new tools for our pharmaceutical customers." Force MultiplieRx is centered around the availability of accurate, consistent, and timely data from a major PBM PBM - play by mail. See play by electronic mail. that many pharmaceutical companies already use to measure national market information. Dendrite's new product will distill dis·till v. 1. To subject a substance to distillation. 2. To separate a distillate by distillation. 3. To increase the concentration of, separate, or purify a substance by distillation. the raw nationwide data to sales territory levels. Nightly updates for each representative will highlight changes in their local doctors' prescribing patterns and identify the need to modify the representative's sales approach accordingly. However, to protect patient confidentiality patient confidentiality Medical practice A Pt's right to privacy and freedom from public dissemination of information that the Pt regards as being of a personal nature. See HIPAA, Medical privacy. , the data do not include patient identity. The data utilized by Force MultiplieRx offer numerous benefits not available from the existing prescription data supplied to pharmaceutical sales representatives: Timeliness -- The Force MultiplieRx database will be updated daily with information supplied by the PBM that is as little as 30 hours old, compared with a monthly update of information that is 10 to 12 weeks old from other sources. Consistency -- The new system will allow reps to analyze trends in actual prescriptions written by individual physicians within their territory. Granularity -- Existing sources commonly supply summarized and projected data on the number of prescriptions written for each drug, while PBM data are linked to the specific prescribing physician and include some general patient demographic information. The software and nightly data feeds are expected to ship in Quarter 4, 1997. About Dendrite Dendrite International, Inc. provides comprehensive enterprise-wide customer management solutions used to manage, coordinate and control the activities of large sales organizations in complex selling environments. The Company's modular software products convert massive amounts of data into actionable information and facilitate enterprise-wide communications between all levels of the sales and marketing organization, as well as other functional areas of the client corporation. Dendrite has two major divisions: the Healthcare Division, which is the largest supplier of customer management systems to the global pharmaceutical industry; and the Consumer Business Division, which serves the over-the-counter drug over-the-counter drug A therapeutic agent that does not require a prescription, which the FDA feels can be safely self-prescribed by non-physicians. Cf Prescription drug, Under-the-counter. , cosmetics and consumer packaged goods (CPG CPG central pattern generators. ) industries worldwide. In the healthcare field, Dendrite offers the market-leading Series 6 pharmaceutical sales automation software. ForceOne, the CPG system, is a high value-added solution, based on an in-depth understanding of merchandising, and offers comprehensive service and support that has been the hallmark of Dendrite's business since its inception. Headquartered in Morristown, New Jersey Morristown is a town in Morris County, New Jersey, United States. As of the United States 2000 Census, the town population was 18,544. Its estimated population in 2004 was 18,842. It is the county seat of Morris CountyGR6. , Dendrite employs over 600 people in 12 offices around the world. For more information, see the company's web site: http://www.drte.com. -0- Note to Editors: Dendrite is a registered trademark of Dendrite Delaware, Inc. and Series 6, ForceOne and Force MultiplieRx are trademarks of Dendrite Delaware, Inc. This press release may contain forward-looking statements that may be viewed as predicting future events or outcomes with respect to Dendrite and its business. The predictions embodied in these statement will involve risks and uncertainties and, accordingly, Dendrite's actual results may differ significantly from the results discussed or implied in such forward-looking statements. For more information, contact John E. Bailye, President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , or George Robson, CFO See Chief Financial Officer. , Dendrite International, Inc., 1200 Mt. Kemble Ave., Morristown, NJ 07960; Telephone: 201/425-1200. CONTACT: Dendrite International, Inc. John E. Bailye, President & CEO George Robson, CFO 201/425-1200 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion